---
$id: https://graph.org.ai/products/commodity/51111638
$type: Product
source: UNSPSC
code: "51111638"
title: "Exatecan"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Exatecan

**UNSPSC Code**: 51111638
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a camptothecin analogue with the molecular formula C24H22FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OC71PP0F89, chemically known as 10h,13h-benzo(de)pyrano(3,4:6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1s-trans)- but generally known as exatecan, which bears US NIH Compound Identifier 151115. The term EXATECAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). Most nations schedule exatecan under HS 29399900 and SITC 54149. As of Q4 2014, EXATECAN remains the US FDA Preferred Term for this commodity. Exatecan bears US NLM identifiers UMLS ID C0965941 and NCI Concept Code C66720. SMILES: CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O.

